Skip to main content
Clinical Trials/DRKS00027093
DRKS00027093
Completed
N/A

Evaluation and feasibility study of telemedicine-based self-sampling for SARS-CoV-2 - 2MINF02 (egePan)

etzwerk Universitätsmedizin Klinikum rechts der Isar der TU München0 sites100 target enrollmentDecember 3, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
COVID-19
Sponsor
etzwerk Universitätsmedizin Klinikum rechts der Isar der TU München
Enrollment
100
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 3, 2021
End Date
October 31, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
etzwerk Universitätsmedizin Klinikum rechts der Isar der TU München

Eligibility Criteria

Inclusion Criteria

  • Indication for SARS\-CoV\-2 testing as per local recommendation
  • \- Access for using an Android or iOS\-Smartphone that is compatible with the Study software application
  • \- Age \=18 years
  • \- Informed consent

Exclusion Criteria

  • \- Current active, laboratory confirmed SARS\-CoV\-2 infection
  • \- Mental deficiency or any other condition that results in lacking understanding of the provided study information

Outcomes

Primary Outcomes

Not specified

Similar Trials